Literature DB >> 16388582

Structural changes of phenylalanine 338 and histidine 447 revealed by the crystal structures of tabun-inhibited murine acetylcholinesterase.

Fredrik Ekström1, Christine Akfur, Anna-Karin Tunemalm, Susanne Lundberg.   

Abstract

Organophosphorus compounds (OPs) interfere with the catalytic mechanism of acetylcholinesterase (AChE) by rapidly phosphorylating the catalytic serine residue. The inhibited enzyme can at least partly be reactivated with nucleophilic reactivators such as oximes. The covalently attached OP conjugate may undergo further intramolecular dealkylation or deamidation reactions, a process termed "aging" that results in an enzyme considered completely resistant to reactivation. Of particular interest is the inhibition and aging reaction of the OP compound tabun since tabun conjugates display an extraordinary resistance toward most reactivators of today. To investigate the structural basis for this resistance, we determined the crystal structures of Mus musculus AChE (mAChE) inhibited by tabun prior to and after the aging reaction. The nonaged tabun conjugate induces a structural change of the side chain of His447 that uncouples the catalytic triad and positions the imidazole ring of His447 in a conformation where it may form a hydrogen bond to a water molecule. Moreover, an unexpected displacement of the side chain of Phe338 narrows the active site gorge. In the crystal structure of the aged tabun conjugate, the side chains of His447 and Phe338 are reversed to the conformation found in the apo structure of mAChE. A hydrogen bond between the imidazole ring of His447 and the ethoxy oxygen of the aged tabun conjugate stabilizes the side chain of His447. The displacement of the side chain of Phe338 into the active site gorge of the nonaged tabun conjugate may interfere with the accessibility of reactivators and thereby contribute to the high resistance of tabun conjugates toward reactivation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16388582     DOI: 10.1021/bi051286t

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  26 in total

1.  Productive reorientation of a bound oxime reactivator revealed in room temperature X-ray structures of native and VX-inhibited human acetylcholinesterase.

Authors:  Oksana Gerlits; Xiaotian Kong; Xiaolin Cheng; Troy Wymore; Donald K Blumenthal; Palmer Taylor; Zoran Radić; Andrey Kovalevsky
Journal:  J Biol Chem       Date:  2019-05-28       Impact factor: 5.157

2.  Effects of Anticholinesterases on Catalysis and Induced Conformational Change of the Peripheral Anionic Site of Murine Acetylcholinesterase.

Authors:  Fan Tong; Rafique M Islam; Paul R Carlier; Ming Ma; Fredrik Ekström; Jeffrey R Bloomquist
Journal:  Pestic Biochem Physiol       Date:  2013-07-01       Impact factor: 3.963

3.  HI-6 assisted catalytic scavenging of VX by acetylcholinesterase choline binding site mutants.

Authors:  Nikolina Maček Hrvat; Suzana Žunec; Palmer Taylor; Zoran Radić; Zrinka Kovarik
Journal:  Chem Biol Interact       Date:  2016-04-12       Impact factor: 5.192

4.  Crystal structures of human carboxylesterase 1 in covalent complexes with the chemical warfare agents soman and tabun.

Authors:  Christopher D Fleming; Carol C Edwards; Stephen D Kirby; Donald M Maxwell; Philip M Potter; Douglas M Cerasoli; Matthew R Redinbo
Journal:  Biochemistry       Date:  2007-04-04       Impact factor: 3.162

5.  The present approaches to the development of prophylactic and therapeutic antidotes against nerve agents.

Authors:  Jiří Kassa; Jiří Bajgar; Kamil Kuča; Kamil Musílek; Jana Karasová
Journal:  Interdiscip Toxicol       Date:  2008-06

6.  The impact of crystallization conditions on structure-based drug design: A case study on the methylene blue/acetylcholinesterase complex.

Authors:  Orly Dym; Wanling Song; Clifford Felder; Esther Roth; Valery Shnyrov; Yacov Ashani; Yechun Xu; Robbie P Joosten; Lev Weiner; Joel L Sussman; Israel Silman
Journal:  Protein Sci       Date:  2016-03-28       Impact factor: 6.725

7.  Flexibility versus "rigidity" of the functional architecture of AChE active center.

Authors:  Avigdor Shafferman; Dov Barak; Dana Stein; Chanoch Kronman; Baruch Velan; Nigel H Greig; Arie Ordentlich
Journal:  Chem Biol Interact       Date:  2008-04-08       Impact factor: 5.192

8.  Targeted synthesis of 1-(4-hydroxyiminomethylpyridinium)-3-pyridiniumpropane dibromide--a new nerve agent reactivator.

Authors:  Kamil Kuca; Kamil Musilek; Martin Paar; Daniel Jun; Petr Stodulka; Martina Hrabinova; Jan Marek
Journal:  Molecules       Date:  2007-08-20       Impact factor: 4.411

9.  A comparison of the neuroprotective efficacy of newly developed oximes (K117, K127) and currently available oxime (obidoxime) in tabun-poisoned rats.

Authors:  Jiri Kassa; Jana Zdarova Karasova; Kamil Musilek; Kamil Kuca; And Young-Sik Jung
Journal:  Toxicol Mech Methods       Date:  2009-03       Impact factor: 2.987

10.  Selective and irreversible inhibitors of mosquito acetylcholinesterases for controlling malaria and other mosquito-borne diseases.

Authors:  Yuan-Ping Pang; Fredrik Ekström; Gregory A Polsinelli; Yang Gao; Sandeep Rana; Duy H Hua; Björn Andersson; Per Ola Andersson; Lei Peng; Sanjay K Singh; Rajesh K Mishra; Kun Yan Zhu; Ann M Fallon; David W Ragsdale; Stephen Brimijoin
Journal:  PLoS One       Date:  2009-08-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.